Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06848530 · ClinicalTrials.gov registry record · NA
Neurophysiology of the Basal Ganglia, Thalamus, and Cerebellum in Patients With Movement Disorders
A NA study of Movement Disorders, sponsored by University of Pennsylvania.
- Recruiting
- Registry status
- NA
- Development phase
- 100
- Enrollment target
- 1
- Study location
NCT06848530: Recruiting NA study of Movement Disorders, sponsored by University of Pennsylvania.
NCT06848530 is a NA study of Movement Disorders that is actively recruiting participants, run by University of Pennsylvania. The registered enrollment target is 100 participants, below the 1,064-participant average among 26 other Movement Disorders trials with a reported enrollment target (91% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06848530, a NA study of Movement Disorders, is actively recruiting participants, sponsored by University of Pennsylvania.
- RECRUITING
- Registry status
- NA
- Development phase
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
The research study is being conducted to better understand parts of the human brain called the cortex, basal ganglia, thalamus, and cerebellum in patients with movement disorders (such as Parkinson's disease, essential tremor, dystonia, or ataxia). These brain structures are involved in movement disorders. This study attempts to better understand the brain electrical activity associated with these disorders, both in patients with and without deep brain stimulation (DBS). Recordings are made from the scalp with a noninvasive electrode and/or through the DBS stimulator if the participant has a stimulator model that is able to sense brain activity. These recordings are analyzed along with measures of movement disorder symptoms to identify brain signal signatures of symptoms.
Primary Outcome
Spatiotemporal patterns of brain neural activity (neural signal biomarkers / neurophysiologic signatures) associated with movement disorders symptoms.
Conditions Studied
Interventions
- OTHER Prescribed Medications
- OTHER Deep brain stimulation adjustment
Study Locations (1)
Pennsylvania
- Pennsylvania Hospital - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2025-12-10 |
| Est. Completion | 2030-04 |
| Phase | NA |
What NCT06848530 shows while recruiting
NCT06848530 is an interventional study that assigns participants to a tested intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 1,064-participant average among 26 other Movement Disorders trials with a reported enrollment target (91% lower).
The record links to 1 condition, with Movement Disorders appearing as the primary indexed condition, and to 2 interventions - of which Prescribed Medications is the first listed.
NCT06848530 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT06848530 about?
NCT06848530 is a clinical study titled "Neurophysiology of the Basal Ganglia, Thalamus, and Cerebellum in Patients With Movement Disorders". The research study is being conducted to better understand parts of the human brain called the cortex, basal ganglia, thalamus, and cerebellum in patients with movement disorders (such as Parkinson's disease, essential tremor, dystonia, or ataxia). These brain structures are involved in movement dis...
What is the current status of trial NCT06848530?
This trial is currently recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2025-12-10. Estimated completion is 2030-04.
What conditions does trial NCT06848530 study?
This clinical trial studies the following conditions: Movement Disorders.
What interventions are being tested in trial NCT06848530?
The interventions under investigation include: Prescribed Medications (OTHER), Deep brain stimulation adjustment (OTHER).
Who is sponsoring clinical trial NCT06848530?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06848530 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Movement Disorders
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06848530's enrollment target sits among peer trials
100 13th of 26 higher than 11 of 26 other Movement Disorders trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Movement Disorders trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Analysis of Human Movement With Assistive Devices
RECRUITING · NA
-
Non-invasive BCI-controlled Assistive Devices
RECRUITING · NA
-
Neurophysiological, Behavioral, and Cognitive Networks in Movement Disorders
RECRUITING · NA
-
Moderate Versus High Volume Light-Moderate Intensity Exercise for People With Moderate Parkinson's Disease
RECRUITING · NA
-
Leg Stretching Using an Exoskeleton on Demand for People With Spasticity
RECRUITING · NA
-
Towards Restoring Complex Movement After Paralysis: Algorithm Development With Healthy Participants
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI